Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Discriminating Precancerous Pathologies from Cervical Cancer

Table 2

Comparison of age and blood parameters in patients with LSIL, HSIL, and cervix cancer and controls.

	Patients with LSIL	Patients with HSIL	Patients with cancer	Controls	Overall
	n = 40	n = 40	n = 30	n = 70
Age (years)	39 ± 9	35 ± 7	46 ± 11^a	35 ± 11	<0.001
WBC count (10^3/µL)	7.7 ± 2.6	7.5 ± 1.9	7.3 ± 2.7	7.9 ± 1.8	0.650
Hemoglobin (g/dL)	13.2 ± 1.2	12.9 ± 1.3	12.2 ± 1.7^b	12.4 ± 1.7	0.020
RDW (%)	13.5 ± 1.5	14.0 ± 1.9	14.4 ± 2.8	13.3 ± 1.9	0.093
Plateletcrit (%)	0.26 ± 0.1	0.26 ± 0.1	0.29 ± 0.1^c	0.24 ± 0.1	0.010
Platelet count (µL)	263 ± 68	257 ± 65	303 ± 92^d	274 ± 70	0.058
MPV (fL)	9.9 ± 1.1	10.1 ± 1.0	10.0 ± 0.8	8.9 ± 1.6^e	<0.001
NLR	2.2 ± 1.1	2.3 ± 1.0	2.7 ± 1.1^c	2.0 ± 0.8	0.016
PLR	123 ± 46	123 ± 34	191 ± 83^a	119 ± 45	<0.001

HSIL: high-grade squamous intraepithelial lesion, LSIL: low-grade squamous intraepithelial lesion, MPV: mean platelet volume, NLR: neutrophil-to-lymphocyte ratio, PLR: platelet-to-lymphocyte ratio, RDW: red cell distribution width, and WBC: white blood cell. ^a between group 3 and groups 1, 2, and 4. ^b between group 3 and group 1. ^c between group 3 and group 4. ^d between group 3 and group 2. ^e between controls and groups 1, 2, and 3.